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In Brief
Basal ganglia plasticity at glutamatergic
synapses is required for motor learning.
Wu et al. report that expression of
endocannabinoid-dependent long-term
depression (eCB-LTD) in the striatum is
dependent on presynaptic input but
independent of postsynaptic cell type.
Furthermore, activation of dopamine
receptors in the striatum bidirectionally
modulates eCB-LTD expression.
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Changes in basal ganglia plasticity at the cortico-
striatal and thalamostriatal levels are required for
motor learning. Endocannabinoid-dependent long-
term depression (eCB-LTD) is known to be a domi-
nant form of synaptic plasticity expressed at these
glutamatergic inputs; however, whether eCB-LTD
can be induced at all inputs on all striatal neurons is
still debatable. Using region-specific Cremouse lines
combined with optogenetic techniques, we directly
investigated and distinguished between corticostria-
tal and thalamostriatal projections. We found that
eCB-LTD was successfully induced at corticostriatal
synapses, independent of postsynaptic striatal spiny
projection neuron (SPN) subtype. Conversely, eCB-
LTD was only nominally present at thalamostriatal
synapses. This dichotomy was attributable to the
minimal expression of cannabinoid type 1 (CB1) re-
ceptors on thalamostriatal terminals. Furthermore,
coactivation of dopamine receptors on SPNs during
LTD induction re-established SPN-subtype-depen-
dent eCB-LTD. Altogether, our findings lay the
groundwork for understanding corticostriatal and
thalamostriatal synaptic plasticity and for striatal
eCB-LTD in motor learning.INTRODUCTION
The basal ganglia are a group of subcortical nuclei that fulfill crit-
ical roles in motor control and action selection (Graybiel et al.,
1994). The input nucleus of the basal ganglia, the striatum, is
composed primarily of two distinct groups of GABAergic spiny
projection neurons (SPNs): direct pathway SPNs (dSPNs), which
project to substantia nigra pars reticulata (SNr) and express D1
dopamine receptors (D1R), and indirect pathway SPNs (iSPNs),
which project to the globus pallidus and express D2 dopamine
receptors (D2R) (Gerfen, 1989; Surmeier et al., 1996, 2007). Stria-
tal SPN dendrites receive intermingled excitatory glutamatergic
inputs from both the cerebral cortex and the thalamus (Dinget al., 2008; Smith et al., 2004). The function and plasticity of
these synapses are modulated by endocannabinoids (eCBs)
(Kano et al., 2009; Kreitzer and Malenka, 2008; Surmeier et al.,
2014), and eCB-dependent long-term depression (eCB-LTD)
is one of the most dominant forms of long-term plasticity ex-
pressed at these glutamatergic synapses (Gerdeman et al.,
2002; Kreitzer and Malenka, 2005, 2007; Shen et al., 2008).
eCBs are released by postsynaptic neurons and act as retro-
grade messengers to activate presynaptic CB1Rs, depressing
neurotransmission (Kano et al., 2009). eCB-LTD induction re-
quires the activation of postsynaptic calcium signaling and acti-
vation of G protein-coupled receptors (Kreitzer and Malenka,
2005). It has been suggested that this form of LTD is dependent
on activation of postsynaptic D2Rs (Kreitzer and Malenka, 2007;
Nazzaro et al., 2012; Shen et al., 2008). However, studies demon-
strating that eCB-LTD can be induced in both SPN subtypes
challenge this view (Bagetta et al., 2011; Wang et al., 2006).
Pharmacological tools have been used to probe the role of
individual neuromodulatory systems in eCB-LTD induction,
including dopaminergic, cholinergic, opioid, and serotoninergic
inputs (Atwood et al., 2014a; Bagetta et al., 2011; Kreitzer and
Malenka, 2005; Mathur et al., 2011; Shen et al., 2007; Wang
et al., 2006). Nevertheless, it is still difficult to isolate the individ-
ual contributions of corticostriatal and thalamostriatal synapses,
given that both are glutamatergic and are intermingled on SPNs
dendrites (Doig et al., 2010). Moreover, these two groups of syn-
apses exhibit very distinct properties: there are stark differences
in release probability, short-term plasticity, and postsynaptic re-
ceptor composition (Ding et al., 2008), suggesting the properties
of their synaptic plasticity might be very different. However, most
previous eCB-LTD studies use conventional electrical stimula-
tion paradigms in which the stimulation electrodes are placed
either intrastriatally or in the white matter. These configurations
inevitably coactivate cortico- and thalamostriatal synapses, as
well as dopaminergic inputs, making it difficult to distinguish
between the individual contributions of these inputs to striatal
synaptic plasticity. We speculate that the discrepancies of past
studies may be the result of nonspecifically exciting heteroge-
neous presynaptic striatal inputs. In order to achieve selective
activation of presynaptic cortico- and thalamostriatal inputs,
we combined region-specific Cre mouse lines with optogenetic
tools to express channelrhodopsin-2 (ChR2) in either cortico-
striatal or thalamostriatal projection neurons. We find thatCell Reports 10, 75–87, January 6, 2015 ª2015 The Authors 75
Figure 1. Optogenetic Activation of Corticostriatal and Thalamos-
triatal Axons in Dorsolateral Striatum
(A) A confocal image of a coronal section from a Thy1-ChR2-YFPmouse. Inset
image shows extensive ChR2-YFP-expressing axons in the CPu from a
different section. Scale bar represents 10 mm. Pf, parafascicular nucleus of the
thalamus; Fr, fasciculus retroflexus.
(B) A coronal section from a Vglut2-Cre;Ai32 mouse imaged as in (A).
(C) Left: a sample image of an oblique horizontal brain slice. SPNs were
sampled in the circled area. Middle: the same slice visualized for green
(Thy1-ChR2-YFP) and red (Drd1-tdTomato) fluorescence under an Arc lamp.
Right: schematic of the recording configuration and optogenetic stimulation
of axon terminals. Labeled as follows: blue, 450 nm blue light; Ctx, cortex; ic,
internal capsule; CPu, caudate putamen; LGP, lateral globus pallidus; Tha,
thalamus.
(D) Left: infrared differential interference contrast image of an SPN under
whole-cell patch-clamp recording. Middle: a sample two-photon image of the
same SPN showing expression of tdTomato (red) and surrounding ChR2-YFP-
expressing axons (green). Scale bar represents 5 mm. Right, a sample two-
photon image showing a dendritic branch of Alexa Fluor 594 (10 mM)-filled SPN
with ChR2-YFP-expressing axons. Scale bar represents 1 mm
(E) Examples of blue-light-evoked EPSCs recorded from SPNs. The AMPA
receptor component (black) was recorded at70mV and NMDAR component
(red) at +40mV. Dashed line indicates 50ms after light stimulation at which the
NMDAR component was measured to calculate the ratio.
76 Cell Reports 10, 75–87, January 6, 2015 ª2015 The Authorswhen other neuromodulatory systems are not activated, eCB-
LTD is reliably induced by (S)-3,5-dihydroxyphenylglycine
(DHPG) at corticostriatal synapses but minimally at thalamostria-
tal synapses, regardless of postsynaptic SPN subtype. We show
that this differential eCB-LTD expression is attributable to CB1R
expression patterns at corticostriatal and thalamostriatal pre-
synaptic terminals. Understanding how striatal neurons integrate
information from different synaptic inputs is essential for deci-
phering basal ganglia function. Our findings suggest that infor-
mation carried by different glutamatergic inputs may undergo
different forms of pathway-specific long-term plasticity that are
critical for their unique roles in motor learning and action
selection.
RESULTS
Optogenetic Targeting of Corticostriatal and
Thalamostriatal Neurons
To achieve selective activation of corticostriatal terminals, we
used Thy1-ChR2-YFP mice (Arenkiel et al., 2007) in which
ChR2 is highly expressed in cortical layer V neurons, but not
thalamic neurons (Figure 1A). We achieved selective expression
of ChR2 in thalamic neurons by crossing Vglut2-Cre mice, in
which Cre recombinase expression is under the control of vesic-
ular glutamate transporter 2 (Vglut2) promoter (Vglut2-Cre line),
with the Ai32 transgenic mouse, in which ChR2-eGFP expres-
sion is Cre dependent (Ai32 line) (Madisen et al., 2012). As Vglut2
is predominantly expressed in glutamatergic neurons in the thal-
amus and in layer IV cortical neurons (Fremeau et al., 2004), we
observed robust ChR2-eGFP expression in thalamus and layer
IV of the cortex in 8- to 10-week-old mice resulting from this
cross (Figure 1B). Axonal fibers expressing ChR2/eGFP densely
innervated the striatum (Figures 1A and 1B, inset). Because
cortical layer IV neurons do not project afferents to the striatum
(Wall et al., 2013), ChR2/eGFP-expressing axons in the striatum
of Vglut2-Cre;Ai32 mice (Figure 1B, inset) arise exclusively from
thalamostriatal inputs. Furthermore, in order to restrict ChR2
expression to a more confined area of the thalamus, we also in-
jected adeno-associated virus (AAV) expressing a Cre-inducible
ChR2-mCherry (AAV-DIO-ChR2-mCherry) into the parafascicu-
lar nucleus (Pf) of the thalamus in Vglut2-Cre mice (Figure S1).
We did not observe any significant difference in NMDA/AMPA
ratio between Vglut2-Cre;Ai32 mice and Vglut2-Cre mice com-
bined with AAV injection (Ai32: 0.26 ± 0.06, n = 5; AAV: 0.23 ±
0.03, n = 17; p = 0.70, Mann-Whitney U test [U test]), which sug-
gests that the majority of the axons activated in Vglut2-Cre;Ai32
mice shared similar properties with those arising from Pf-in-
jected neurons. Therefore, we grouped the data from these
two approaches for simplicity with the abbreviation Vglut2-
Cre;ChR2 mice.
We performed whole-cell patch-clamp recordings in oblique
horizontal brain slices and recorded from SPNs in the dorsolat-
eral striatum (Figures 1C and 1D). In most cases, we also docu-
mented the cell type as dSPN or iSPN by determining the(F) Summary of NMDA/AMPA ratios of corticostriatal (Thy-ChR2-YFP, n =
9) and thalamostriatal (Vglut2-Cre; ChR2, n = 22) synapses. *p < 0.05,
U test.
expression of Drd1-tdTomato or Drd2-GFP (Figure 1D, middle).
Dense ChR2-YFP-expressing axons were observed surround-
ing the SPN dendrites (Figure 1D, right). Next, we tested whether
we could specifically and reliably activate either the corticostria-
tal or thalamostriatal pathway in this paradigm. We delivered
short blue light pulses (0.1–0.15 ms at 450 nm, 0.5–4 mW under
objective) to stimulate ChR2-expressing axons to evoke gluta-
matergic excitatory postsynaptic currents (EPSCs) in SPNs. It
has been shown that corticostriatal synapses have higher
NMDA receptor (NMDAR) components as compared to thala-
mostriatal synapses (Ding et al., 2008). Consistent with this pre-
vious finding, we found that optogenetic stimulation-evoked
EPSCs at corticostriatal synapses also had larger NMDAR
components than at thalamostriatal synapses. The NMDAR
and AMPAR current ratio (NMDA/AMPA ratio) was significantly
larger in Thy1-ChR2-YFP mice than in Vglut2-Cre;ChR2 mice
(Figures 1E and 1F; Thy1-ChR2-YFP: 0.38 ± 0.05, n = 9;
Vglut2-Cre;ChR2: 0.23 ± 0.03, n = 22; p < 0.05, U test). These
results further confirm the reliability of our optogenetic approach
for the selective activation of either corticostriatal or thalamos-
triatal axons in the striatum.
Differential Expression of CB1R-Dependent LTD in
Corticostriatal and Thalamostriatal Synapses on SPNs
Next, we asked if eCB-LTD is expressed in both corticostriatal
and thalamostriatal synapses formed on SPNs. Because this
form of LTD can be modulated by activation of dopamine and
acetylcholine receptors (Kreitzer and Malenka, 2005; Wang
et al., 2006), high-frequency electrical stimulation (eHFS) might
recruit dopaminergic and cholinergic signaling, complicating
LTD induction. To bypass these alternative neuromodulator sys-
tems, we instead directly activated group 1 mGluR by applying
50 mM (S)-DHPG for 10 min to induce LTD. Together, with post-
synaptic depolarization to 50 mV to activate L-type calcium
channels (Kreitzer and Malenka, 2005, 2007), DHPG reliably
induced LTD in almost all of the recorded SPNs in Thy1-ChR2-
YFP mice (16 out of 18, 89% of neurons expressed LTD with
EPSC peaks decreased by more than 20%) (Figures 2A and 2C;
62% ± 3% of baseline, n = 18; p < 0.001, Wilcoxon signed rank
[Wilcoxon]). Surprisingly, in SPNs of Vglut2-Cre;ChR2 mice,
DHPG caused only a small reduction in EPSCs (Figures 2B and
2D; 90%± 4%of baseline, n = 13, p < 0.05,Wilcoxon), suggesting
that this LTD is primarily restricted to corticostriatal afferents.
Next, we investigated whether DHPG-induced eCB-LTD is ex-
pressed in both dSPNs and iSPNs (Figure 1D, middle). eCB-LTD
was reliably induced by DHPG in both dSPNs and iSPNs in Thy1-
ChR2-YFP mice (Figure 2E; dSPN: 63% ± 5% of baseline, n = 8,
p < 0.05,Wilcoxon; iSPNs: 63% ± 4%of baseline, n = 7; p < 0.05,
Wilcoxon; p = 1 for comparison between dSPNs and iSPNs, U
test). In stark contrast, DHPG application produced minimal or
no LTD in either dSPNs and iSPNs in Vglut2-Cre;ChR2mice (Fig-
ure 2F; dSPN: 94% ± 5% of baseline, n = 5, p = 0.795, Wilcoxon;
iSPNs: 87% ± 5% of baseline, n = 5; p = 0.11, Wilcoxon; p = 0.53
for comparison between dSPNs and iSPNs, U test). Consistent
with previous findings that striatal eCB-LTD is expressed pre-
synaptically, paired-pulse ratios (PPRs) were significantly
increased by the LTD induction protocol in both dSPNs and
iSPNs in Thy1-ChR2-YFP mice (Figure 2G; dSPNs: baseline:1.07 ± 0.09, DHPG: 1.32 ± 0.11, n = 8, p < 0.05,Wilcoxon; iSPNs:
baseline: 1.05 ± 0.05, DHPG: 1.21 ± 0.08, n = 7; p < 0.05, Wil-
coxon), suggesting eCB-LTD in corticostriatal terminals was
accompanied by a decrease in presynaptic release probability.
PPRs were not significantly changed in the thalamostriatal syn-
apses of Vglut2-Cre;ChR2 mice (Figure 2H; dSPNs: baseline:
0.57 ± 0.17, DHPG: 0.60 ± 0.15, n = 5, p = 0.63,Wilcoxon; iSPNs:
baseline: 0.79 ± 0.12, DHPG: 0.84 ± 0.14, n = 5; p = 0.31, Wil-
coxon), suggesting the small reduction of EPSCs at thalamos-
triatal synapses was not caused by a presynaptic mechanism.
LTD induced in both dSPNs and iSPNs of Thy1-ChR2-YFP
mice was sensitive to a CB1R antagonist (AM251 5–10 mM), sug-
gesting that LTD is eCB dependent (Figures 3A and 3B; dSPN:
91% ± 5% of baseline, n = 6; p = 0.09, Wilcoxon; iSPN: 95% ±
10% of baseline, n = 8; p = 0.25, Wilcoxon). Interestingly, the
slight LTD observed at thalamostriatal synapses was not sensi-
tive to AM251 (Figure 3C; 84% ± 4% of baseline, n = 6, p =
0.46 comparing to control without AM251, U test), indicating
this is not eCB-dependent LTD. Taken together, these results
suggest that DHPG-induced eCB-LTD in striatal SPNs is input
specific and not postsynaptic cell-type dependent.
It has been shown that dopamine release is critical for inducing
eCB-LTD in the striatum. Specifically, D2R activation is required
for eCB-LTD when induced by eHFS (Bagetta et al., 2011; Kreit-
zer and Malenka, 2005, 2007; Wang et al., 2006). Therefore, we
tested whether DHPG-induced eCB-LTD at corticostriatal and
thalamostriatal synapses requires activation of D1R and D2Rs.
Consistent with previous findings, this form of eCB-LTD was
not NMDAR dependent (Figure S2A; R-CPP 10 mM, 71% ± 4%
of baseline, n = 6; p < 0.05,Wilcoxon). The LTDwas also not sen-
sitive to D1R antagonist (Figure S2B; SCH23390 3 mM, 68% ±
6%of baseline, n = 7; p < 0.05,Wilcoxon). Surprisingly, we found
that D2R antagonist (sulpiride 5 mM) did not prevent eCB-LTD in-
duction by DHPG in either dSPNs and iSPNs (Figures 3D–3F;
dSPNs: 75% ± 6% of baseline, n = 6, p < 0.05, Wilcoxon; iSPNs:
68% ± 7% of baseline, n = 7; p < 0.05, Wilcoxon). In addition, in
the presence of D2R antagonist, eCB-LTD was accompanied by
increased PPRs (dSPNs: baseline: 1.02 ± 0.12, DHPG: 1.14 ±
0.13, n = 6, p < 0.05, Wilcoxon; iSPNs: baseline: 1.04 ± 0.07,
DHPG: 1.28 ± 0.12, n = 7; p < 0.05, Wilcoxon). This finding,
consistent with the data reported in Kreitzer and Malenka
(2005), suggests that prolonged activation of mGluR1/5 and
L-type calcium channels is sufficient to induce eCB-LTD at cor-
ticostriatal synapses. Furthermore, this DHPG LTD-induction
paradigm bypasses the requirement for D2R activation. There-
fore, contrary to previous findings, eCB-LTD can be induced in
both dSPNs and iSPNs in the presence of dopamine receptor
antagonists with this model.
eCB-LTD in Corticostriatal Synapses in Cortex-Specific
Cre Mouse Lines
Although it is generally believed that ChR2 is expressed primarily
in the cortical layer V neurons of Thy1-ChR2-YFP mice (Wang
et al., 2007) and, therefore, that light predominantly stimulates
cortical inputs to the striatum, it is still possible that light may acti-
vate axons arising from other brain areas (Arenkiel et al., 2007). To
ensure more specific expression of ChR2 in cortical neurons, we
took advantage of the Emx1-Cre mouse line in which CreCell Reports 10, 75–87, January 6, 2015 ª2015 The Authors 77
Figure 2. Differential Expression of CB1R-
Dependent LTD in Corticostriatal and
Thalamostriatal Synapses on SPNs
(A) Upper plot: an individual experiment showing
that activation of mGluR1/5 with 50 mM DHPG
induced LTD in SPNs of Thy1-ChR2-YFP mice
(postsynaptic neurons held at 50 mV). Light-
induced paired pulses were evoked every 20 s.
DHPG was applied for 10 min after 10 min of
baseline recording, as indicated by the red bar.
Lower left plot: averaged EPSC traces (1, black)
and drug effect (2, red). Lower right plot: baseline
and drug-effect traces were normalized to the first
EPSC peak to show the changes in paired-pulse
ratio (PPR).
(B) Same as (A), except the SPN was from a
Vglut2-Cre mouse with AAV DIO-ChR2-mCherry
injected in the Pf.
(C and D) Summary of DHPG induced LTD on
SPNs from Thy1-ChR2-YFP mice and Vglut2-
Cre;ChR2-expressing (Ai32- or AAV-injected)
mice. See also Figure S1.
(E and F) Summary of EPSC amplitudes in dSPNs
(filled circles) and iSPNs (open circles) in both
Thy1-ChR2-YFP (E) and Vglut2-Cre;ChR2 (F)
mice.
(C–F) Data are presented as mean ± SEM.
(G and H) Summary PPRs of baseline and 20 min
after DHPG treatment on dSPNs (left) and iSPNs
(right) from Thy1-ChR2-YFP mice (G) and Vglut2-
Cre;ChR2 mice (H).recombinase is expressed in cortical and hippocampal excitatory
neurons (Madisen et al., 2012) and Rbp4-Cre mouse line that
selectively expresses Cre recombinase in a dense population of
layer V cortical neurons (Glickfeld et al., 2013) (Figures 4A and78 Cell Reports 10, 75–87, January 6, 2015 ª2015 The Authors4E). We then tested whether the cortico-
striatal synapses on the SPNs in these
two mouse lines shared similar properties
with corticostriatal synapses of Thy1-
ChR2-YFP mice. Indeed, the NMDA/
AMPA ratios measured from optogeneti-
cally evoked EPSCs recorded in Emx1-
Cre;Ai32 and Rbp4-Cre;Ai32 mice were
similar to those in the Thy1-ChR2-YFP
mouse (Figures S3A and S3B; Emx1-
Cre;Ai32: 0.40 ± 0.06, n = 11; Rbp4-
Cre;Ai32: 0.37 ± 0.04, n = 10; p = 1.0 for
comparison of Emx1-Cre;Ai32 and
Rbp4-Cre;Ai32 with Thy1-ChR2-YFP
mice, U test). In all three mouse lines, the
NMDA/AMPA ratiowas significantly larger
than that recorded in Vglut2-Cre;ChR2
mice (Figure S3B; p < 0.05, U test). These
results indicate that the synaptic proper-
ties of these two mouse lines are similar
to those of corticostriatal synapses re-
corded from Thy1-ChR2-YFP mice.
Using the same DHPG induction proto-
col, eCB-LTD was successfully inducedin Emx1-Cre;Ai32 and Rbp4-Cre;Ai32 mice (Figures 4B and
4C; Emx1-Cre;Ai32 mice 70 ± 8 of baseline, n = 9; p < 0.05, Wil-
coxon; Figures 4F and 4G; Rbp4-Cre;Ai32 mice 66 ± 6 of base-
line, n = 6; p < 0.05, Wilcoxon). The PPRs were also significantly
Figure 3. eCB-LTD Is Not Blocked by D2R
Antagonist
(A and B) The DHPG-induced LTD in corticostriatal
synapses on both dSPNs (A) and iSPNs (B) is
CB1R dependent. CB1R antagonist (AM251 5–
10 mM) was applied throughout the recording
(gray bar).
(C) AM251 did not affect the DHPG-induced LTD
in thalamostriatal synapses.
(D and E) The DHPG-induced LTD in corticostriatal
synapses on both dSPNs (D) and iSPNs (E) is not
blocked by D2R antagonist (sulpiride 5 mM).
(A–E) Data are presented as mean ± SEM.
(F) Summary PPRs of baseline and 20 min after
DHPG treatment on dSPNs (left) and iSPNs (right)
in the presence of sulpiride from Thy1-ChR2-YFP
mice.increased in both mouse lines along with the expression of LTD
(Figures 4D and 4H; Emx1-Cre: baseline: 0.39 ± 0.04, DHPG:
0.48 ± 0.06, n = 9, p < 0.05, Wilcoxon; Rbp4-Cre: baseline:
0.41 ± 0.09, DHPG: 0.52 ± 0.08, n = 6; p < 0.05, Wilcoxon), sug-
gesting a similar presynaptic mechanism of eCB-LTD to the
Thy1-ChR2-YFP mice reported above. We observed that LTD
was induced in all recorded neurons in Emx1-Cre;Ai32 and
Rbp4-Cre;Ai32 mice, suggesting eCB-LTD is present in both
dSPNs and iSPNs. Together, these results further strengthen
our conclusion that eCB-LTD in glutamatergic synapses onto
striatal SPNs is determined by cortical input.
Dopamine Modulation of eCB-LTD Induced by
Spike-Timing-Dependent Protocol
Our results indicate that dopamine is not required in DHPG-
induced eCB-LTD. However, eCB-LTD could also be induced
by other induction protocols, such as eHFS or spike-timing-
dependent plasticity (STDP) induction protocol (Bagetta et al.,
2011; Gerdeman et al., 2002; Kreitzer and Malenka, 2005,Cell Reports 10, 75–82007; Shen et al., 2008; Wang et al.,
2006). We attempted to induce LTD with
optogenetic high-frequency-stimulation
(oHFS) in brain slices made from either
Thy1-ChR2-YFP or Vglut2-Cre;ChR2
mice (Figure S4). However, because
ChR2 and ChR2(H134B) are subject to
strong inactivation and desensitization
(Lin et al., 2009), the synaptic release
could not reliably follow the optical stimu-
lation when the stimulation frequency is
above 20 Hz (Figure S4), preventing us
from directly testing whether eCB-LTD
induced by oHFS stimulation protocol is
also input specific. Thus, we asked
whether DHPG protocol and high-fre-
quency-stimulation (HFS) share similar
features by testing the occlusive effect
of DHPG on HFS-induced LTD. Indeed,
with local electrical stimulation, LTD was
induced in only iSPNs and was occludedby DHPG (Figure S5), suggesting DHPG-induced eCB-LTDs
share a similar mechanism.
We next investigated whether eCB-LTD induced by a Hebbian
form of STDP is also input specific. Previous studies have shown
that eCB1-LTD could be induced by a ‘‘post-pre’’-STDP proto-
col, i.e., pairing postsynaptic spiking preceding presynaptic
release (Figure 5A) (Nazzaro et al., 2012; Shen et al., 2008). In
addition, this post-pre-STDP protocol could trigger eCB-depen-
dent LTDonly in iSPNand not in dSPN (Shen et al., 2008).We first
tested whether LTD could be induced in dSPNs or iSPNs by pair-
ing cortical afferent stimulation using optogenetic stimulation
(Thy1-ChR2-YFP mice) with preceding postsynaptic spikes in
short bursts that were repeated at a theta frequency (5 Hz,
oSTDP pairing protocol; Figure 5A). Surprisingly, we found that
LTD at corticostriatal synapses was only induced in dSPNs,
but not in iSPNs (Figures 5B–5E; dSPN: 72% ± 4% of baseline,
n = 6; p < 0.05, Wilcoxon; iSPN: 91% ± 12% of baseline, n = 9;
p = 0.50, Wilcoxon). Previous studies of striatal LTD that used
conventional local electrical stimulation to evoke glutamatergic7, January 6, 2015 ª2015 The Authors 79
Figure 4. Optogenetic Activation of Corticostriatal Synapses Using Emx1-Cre and Rbp4-Cre Mice
(A and E) Confocal images of coronal sections across cortex and thalamus of Emx1-Cre;Ai32 (A) and Rbp4-Cre;Ai32 (E) mice. Inset image shows the ChR2-eGFP
expressing axon terminals in the striatum (CPu) from different sections. Tha, thalamus. Scale bar represents 10 mm.
(B and F) Left: an individual experiment of LTD induced in SPNs of Emx1-Cre;Ai32 (B) and Rbp4-Cre;Ai32 (F) mice. Upper right: averaged EPSC traces of baseline
(1, black) and drug effect (2, red). Lower right: normalized EPSC to show the changes in PPR.
(C and G) Summary of DHPG-induced LTD on SPNs from Emx1-Cre;Ai32 (C) and Rbp4-Cre;Ai32 (G) mice. Data are presented as mean ± SEM.
(D and H) Summary PPRs of baseline and 20 min after DHPG treatment on SPNs from Emx1-Cre;Ai32 (D) and Rbp4-Cre;Ai32 (H) mice. *p < 0.05, Wilcoxon.
Box-and-whisker plots indicate the minimum, 25th, 50th, 75th, and maximum percentiles.synaptic transmission also inevitably activated en passant dopa-
mine fibers (Shen et al., 2008). It is therefore possible that coac-
tivation of D1Rs reduces LTD in dSPNs and, conversely, D2R
activation is required for oSTDP-LTD in iSPNs. To directly test
this hypothesis, we re-examined the role of D1R and D2Rs in
oSTDP-LTD using D1R and D2R agonists. In dSPNs, we found
that D1R agonist (SKF 81297 3 mM) prevented oSTDP-LTD
induction (Figure 5F; 95% ± 4% of baseline, n = 5; p = 0.44, Wil-
coxon), which resembles the LTD induced by electrical stimula-
tion using the same pairing protocol (Shen et al., 2008). On the
other hand, in iSPNs, oSTDP-LTD was successfully induced in
the presence of D2R agonist (quinpirole 10 mM) (Figure 5G;
81% ± 3% of baseline, n = 7; p < 0.05, Wilcoxon). It is worth
mentioning that our oSTDP-LTD results obtained from control
conditions closely resemble what was shown in previous find-
ings, where D1R and D2Rs activation was abolished by either
dopamine receptor antagonists or dopamine depletion (Shen
et al., 2008). Lastly, oSTDP-LTD induced in both dSPNs and
iSPN (in quinpirole) was blocked by AM251 (Figures 5F and 5G;
dSPN: 101% ± 3% of baseline, n = 5; p = 0.63, Wilcoxon; iSPN
in quinpirole: 98% ± 6% of baseline, n = 5; p = 0.81, Wilcoxon),
suggesting that oSTDP-LTD at corticostriatal synapses on both
dSPNs and iSPNs are CB1R dependent. Together, these data
showed that eCB-LTD could be induced at corticostriatal synap-
ses using an oSTDP induction protocol and that corticostriatal
synapses on both dSPNs and iSPNs are capable of eCB-LTD
expression. In addition, bidirectional modulatory effects exerted
by activation of different dopamine receptors in dSPNs and
iSPNs underlie the postsynaptic cell-type dependence reported80 Cell Reports 10, 75–87, January 6, 2015 ª2015 The Authorsin previous studies: using conventional local electrical stimula-
tion, coactivation of D1R in dSPNs could mask eCB-LTD,
whereas activation of D2R could facilitate eCB-LTD in iSPNs.
Next, we asked if LTD could be induced by the same oSTDP
paradigm at thalamostriatal synapses. Interestingly, the same
post-pre pairing protocol (Figure 5A) successfully induced
LTD at thalamostriatal synapses in all the recorded SPNs
(nine out of nine) (Figures 5H and 5I; 82% ± 3% of baseline,
n = 9; p < 0.05, Wilcoxon). This LTD, however, was not blocked
by AM251 (Figure 5J; 70% ± 8% of baseline, n = 7; p < 0.05,
Wilcoxon), again suggesting that oSTDP-LTD at thalamostriatal
synapses is not CB1R dependent. We further tested whether
D2R agonist could enhance LTD by facilitating eCB release
(Giuffrida et al., 1999; Wang et al., 2006). However, D2R agonist
(quinpirole 10 mM) did not enhance the LTD at thalamostriatal
synapses in iSPNs (Figure 5J; 70% ± 6% of baseline, n = 7;
p < 0.05, Wilcoxon; p = 0.11, compared to control, U test).
Finally, this LTD was blocked by NMDAR antagonist (R-CPP
10 mM) (Figure 5K; 95% ± 7% of baseline, n = 5; p = 0.44, Wil-
coxon), indicating that LTD induced by oSTDP paradigm at tha-
lamostriatal synapses is NMDAR dependent rather than eCB
dependent. This finding, together with a recent report (Ellender
et al., 2013), suggests that thalamostriatal synapses express a
different form of LTD that does not involve CB1R activation.
Differential Expression of Cbr1 mRNA in Cortical and
Thalamic Projection Neurons
What could cause such a difference in eCB-LTD induction in cor-
ticostriatal and thalamostriatal synapses? It is possible that eCB
Figure 5. Spike-Timing-Dependent LTD at Corticostriatal Synapses
(A) Left: the theta-burst optogenetic spike-timing dependent plasticity (oSTDP)
pairing protocol for induction of LTD in Thy1-ChR2-YFP mice. Right action
potentials and EPSPs recorded from postsynaptic SPNs during induction.
(B and C) An individual experiment showing the change of corticostriatal EPSP
amplitude in a dSPN (B) and an iSPN (C) before and after post-pre pairing STDP
induction. Inset: averaged EPSP traces are collected from10 to 15 traces of the
first 5 min of baseline (1, black) and the last 5 min after induction (2, red).production and release are different at these synapses. D2R acti-
vation can facilitate eCB production (Giuffrida et al., 1999; Wang
et al., 2006) and induction of eCB-LTD (Kreitzer and Malenka,
2007). Indeed, when using an oSTDP induction protocol, D2R
agonist is required for inducing eCB-LTD at corticostriatal
synapses in iSPNs. However, this could not explain why LTD
at thalamostriatal synapses is insensitive to CB1R antagonism.
Furthermore, the DHPG protocol, which combined postsynaptic
depolarization and mGluR1/5 activation, could bypass the acti-
vation of postsynaptic dopamine receptors. Striatal eCB-LTD
expression requires activation of CB1Rs on the presynaptic ter-
minals. Therefore, it is possible that the level of CB1R expression
is different at corticostriatal and thalamostriatal terminals. To
directly test this hypothesis, we first examined the expression
levels of Cbr1, the gene that encodes CB1R, in cortical and
thalamic projection neurons (Figures 6A and 6B). Using in situ hy-
bridization, we found that Cbr1 mRNA was highly expressed in
cortical neurons, especially in layer V neurons, whereas Cbr1
mRNA was barely detected in thalamus (Figure 6C). To confirm
the specificity of Cbr1 expression in cortical projection neurons,
we quantified the number of layer V/VI cells that contained Cbr1
mRNA. We found that nearly 30% of cortical layer V cells are
Cbr1 positive, while less than 3% thalamic cells expressed
Cbr1 mRNA (Figure 6D; cortical layer V: 26% ± 3%, thalamus
2% ± 1%, n = 8 slices from two animals, p < 0.01, U test). These
distinctions in Cbr1 expression levels revealed that differential
CB1R signaling might contribute to the dichotomous regulation
of cortical and thalamic inputs to SPNs.
CB1R Is Colocalized with Cortical, but Not Thalamic,
Terminals
To further provide an estimate of CB1R protein expression at
these presynaptic axonal terminals, we performed immunostain-
ing in striatal brain slices. It is well established that presynaptic
terminals originating from the cortex and thalamus contain
different types of Vgluts: corticostriatal terminals express Vglut1
and thalamostriatal terminals express Vglut2 (Fremeau et al.,
2004). Therefore, we performed double immunostaining with
one antibody against either Vglut1 or Vglut2 and a second anti-
body against CB1R (Figures 6E–6G). We found that CB1R is
highly expressed in the dorsal striatum, in agreement with previ-
ous findings (Kano et al., 2009; Uchigashima et al., 2007).
Furthermore, we found that many CB1R puncta are highly(D and E) Summary of EPSP amplitudes in dSPNs (D) and iSPNs (E) in Thy1-
ChR2-YFP mice.
(F) D1R agonist (SKF81297 3 mM; blue) and CB1R antagonist (AM251 5–10 mM;
gray) suppressed oSTDP-LTD in dSPNs.
(G) oSTDP-LTD was successfully induced in iSPNs in D2R agonist (quinpirole
10 mM; blue) and was blocked by CB1R antagonist (gray).
(H) An individual experiment showing the change of thalamostriatal EPSP
amplitude.
(I) Summary of EPSP amplitudes in SPNs from Vglut2-ChR2 mice.
(J) The oSTDP-LTD in thalamostriatal synapses on dSPNs was not blocked by
CB1R antagonist (orange) and not facilitated by D2R agonist (dark orange).
(K) The oSTDP-LTD in thalamostriatal synapses on SPNs was blocked by
NMDAR antagonist (R-CPP 10 mM).
Data are represented as mean ± SEM. Gray bars indicate the period of drug
application, and blue bars indicate the period for oSTDP induction.
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Figure 6. Differential Expression of CB1R at
Cortico- and Thalamostriatal Inputs
(A) A sagittal section of brain slice showing the
in situ hybridization of Cbr1 mRNA. Signal pre-
sented in pseudocolor (red).
(B) Enlarged images of Cbr1 in situ hybridization in
cortex (left) and in thalamus (coronal section,
right). Labeled as follows: Ctx, cortex; II–VI, layer
of cortex; cc, corpus callosum; Tha, thalamus;
Pf, parafascicular nucleus of the thalamus; Fr,
fasciculus retroflexus.
(C) Overlapped images of Cbr1 in situ hybridiza-
tion (red) and DAPI (blue) in cortex (left) and in
thalamus (right) in the boxed areas in (B).
(D) Summary of percentage of Cbr1-positive cells
in cortical layer V and thalamus (Tha; n = 8, 4 slices
each from two mice; *p < 0.05, U test).
(E and F) Double IHC detected Vglut1(E) and
Vglut2(F) (left, red) and CB1R (middle, green) and
merged image (right) in dorsolateral stratum.
(G) High-magnification images of merged images
from dotted box areas in (E) and (F) revealed
CB1Rwasmore highly expressed in corticostriatal
(Vglut1 positive, left) than in thalamostriatal (Vglut2
positive, right) axon terminals.
(H) Summary of CB1R expression levels on Vglut1-
and Vglut2-positive immunoreactive puncta (n =
10; 2 slices each from five mice; *p < 0.05, U test).
In (D) and (H), box-and-whisker plots indicate
the minimum, 25th, 50th, 75th, and maximum
percentiles.colocalized with Vglut1-positive terminals. In stark contrast,
CB1R puncta were rarely colocalized with Vglut2-positive termi-
nals. To estimate the degree of colocalization of CB1Rs with82 Cell Reports 10, 75–87, January 6, 2015 ª2015 The Authorsthese terminals, we quantified the CB1R
density on Vglut1- and Vglut2-containing
axonal boutons (see the Experimental
Procedures and Figure S6). We found
that CB1R density is significantly higher
on Vglut1-positive terminals than on
Vglut2-positive terminals (Figure 6H;
Vglut1: 12.2 ± 1.7 and Vglut2: 2.9 ± 0.8
CB1R immunofluorescence/pixel; n = 10
slices of five mice; p < 0.05, U test). Our
results thus demonstrate a dramatic dif-
ference in CB1R expression pattern in
corticostriatal and thalamostriatal synap-
ses. This lack of CB1R expression on tha-
lamostriatal terminals explains why eCB-
LTD is nearly absent at thalamostriatal
synapses.
Lack of CB1 Receptor Modulation
at Thalamostriatal Synapses
Because we observed a dramatic differ-
ence in the CB1R expression pattern at
cortico- and thalamostriatal terminals,
we speculated that direct activation of
CB1Rs by a CB1R agonist would pro-duce a neuromodulatory effect. It has been shown that pro-
longed activation of CB1Rs alone (without postsynaptic depolar-
ization, holding potential =70 mV) is sufficient to induce LTD in
Figure 7. Direct Activation of CB1R Reveals a Presynaptic Mecha-
nism in Pathway-Specific LTD in Corticostriatal and Thalamostriatal
Synapses
(A) Left: individual experiments showing that activation of CB1R with CB1R
agonist (Win-2 2 mM) for 20 min followed by 20 min application of CB1R
antagonist (AM251 5–10 mM) induced a larger LTD in SPNs of Thy1-ChR2-YFP
(upper left) than in Vglut2;ChR2 (lower left) mice. Middle: averaged EPSC
traces for baseline (1, black) and for drug effect (2, red). Right: normalized
EPSPs to show the changes in PPR.
(B) Summary of Win-2 induced LTD on SPNs from Thy1-ChR2-YFP (blue) and
Vglut2-Cre;ChR2 (orange) mice. Error bar indicates SEM.
(C) Summary time courses of PPR changes during Win-2 induced LTD
on SPNs showing that PPRs were increased in Thy1-ChR2-YFP (blue) but not
Vglut2-Cre; ChR2 (orange) mice. Error bar indicates SEM. *p < 0.05, Wilcoxon.
(D and F) Left: Summary time courses of Win-2-induced LTD on SPNs from
Emx1-Cre;Ai32 (D) and Rbp4-Cre;Ai32 (F) mice. Error bar indicates SEM.
Upper right: averaged EPSC traces for baseline (1, black) and for drug effect (2,
red). Lower right: normalized EPSCs.
(E and G) Summary PPRs of baseline and 20 min after Win-2 treatment on
SPNs from Emx1-Cre; Ai32 (E) and Rbp4-Cre; Ai32 (G) mice. *p < 0.05, Wil-
coxon. Box-and-whisker plots indicate the minimum, 25th, 50th, 75th, and
maximum percentiles.striatal glutamatergic synapses (Kreitzer and Malenka, 2005). If
the difference in presynaptic CB1R density accounts for the
input-specific eCB-LTD, direct activation of presynaptic CB1R
should recapitulate the difference in LTD between cortical and
thalamic inputs. To test this, we applied 2 mM Win55,212-2
(Win-2), a selective CB1R agonist, for 20 min, followed by a
CB1R antagonist (AM251 5-10 mM), while washing out Win-2
to ensure the changes in EPSC amplitudes were long-lasting.
We found that Win-2 strongly reduced EPSCs at corticostriatal
synapses, and this reduction in EPSCs was indeed long-lasting.
In agreement with a presynaptic mechanism, we observed an in-
crease in PPRs in Thy1-ChR2-YFP mice treated with Win-2 (Fig-
ures 7A–7C; EPSCs: 39% ± 3% of baseline, n = 11, p < 0.001;
PPRs: baseline: 1.11 ± 0.10, Win-2: 1.37 ± 0.09, n = 11, p <
0.01, Wilcoxon). Although we also observed a reduction in
EPSC amplitudes by Win-2 in Vglut2-Cre;ChR2 mice (Figures
7A and 7B; EPSCs: 77% ± 2% of baseline, n = 6, p < 0.05, Wil-
coxon), the reduction level was significant smaller than in Thy1-
ChR2-YFP mice (p < 0.05, U test) and there was no change in
PPR (Figure 7C; PPRs: baseline: 0.65 ± 0.09, Win-2: 0.67 ±
0.10, n = 6, p = 0.44, Wilcoxon), suggesting the Win-2 effect
was not presynaptic. The reduction in EPSC amplitudes in
Vglu2-Cre;ChR2 mice might be caused by nonspecific (Ma´tya´s
et al., 2006) or postsynaptic effects (Kreitzer et al., 2002). These
results suggest that the differential eCB-LTD between cortical
and thalamic inputs is due to a difference in presynaptic CB1R
density. Finally, we confirmed our findings by testing Win-2-
induced LTD in cortex-specific mouse lines. In both Emx1-
Cre;Ai32 and Rbp4-Cre;Ai32 mice, more than 45% reduction in
EPSC amplitudes was induced by Win-2 (Figures 7D and 7F;
Emx1-Cre: 52% ± 3% of baseline, n = 7, p < 0.05; Rbp4-Cre:
54% ± 5% of baseline, n = 7, p < 0.05; Wilcoxon). The reduction
in EPSC amplitudes was significantly larger in cortex-specific
Cre mice than in Vglut2-Cre;ChR2 mice (p < 0.05, U test). LTD
was accompanied by increases in PPR (Figures 7E and 7G;
Emx1-Cre: baseline: 0.62 ± 0.14, Win-2: 0.83 ± 0.18, n = 7, p <
0.05; Rbp4-Cre: baseline: 0.50 ± 0.08, Win-2: 0.65 ± 0.09, n =
7, p < 0.05, Wilcoxon), suggesting the effect of Win-2 resulted
from selective action on presynaptic terminals of cortical inputs.
Thus, our results demonstrate that the input-specific eCB-LTD
on striatal SPNs is due to a differential activation of presynaptic
CB1Rs at cortical and thalamic terminals.
DISCUSSION
In this study, we take advantage of optogenetic approaches
to examine presynaptic input- and postsynaptic cell-type
specificity in striatal synaptic plasticity. Our tools allow us to
selectively trigger glutamate release from corticostriatal or thala-
mostriatal synapses without coactivating other neuromodulatory
systems. We report that eCB-LTD induced by DHPG and oSTDP
at glutamatergic synapses on striatal SPNs is observed only
at corticostriatal synapses, not at thalamostriatal synapses.
This is due to differential expression of CB1Rs at presynaptic
glutamatergic boutons; while CB1Rs are selectively expressed
on axon terminals of cortical inputs, they are mostly absent on
thalamic terminals (Figure S7). This dichotomy in CB1R expres-
sion patterns allows differential eCB-LTD expression atCell Reports 10, 75–87, January 6, 2015 ª2015 The Authors 83
corticostriatal synapses while preventing eCB-LTD of thalamos-
triatal synapses.
eCB-LTD in Direct and Indirect Pathway SPNs
The question of selective eCB-LTD expression in iSPNs and not
dSPNs continues to be a subject of debate in the field (Kreitzer
and Malenka, 2007). Several observations support postsynaptic
cell-type specificity of LTD induction: (1) selective blockade of
D2Rs has been shown to abolish eCB-LTD in SPNs, (2) eCB-
LTD has been shown to be absent in dSPNs (Kreitzer and Mal-
enka, 2007; Nazzaro et al., 2012; Shen et al., 2008), and (3)
D2R activation can facilitate eCB release (Giuffrida et al., 1999;
Wang et al., 2006) and eCB-LTD in iSPNs (Kreitzer and Malenka,
2007). However, those views are challenged by studies demon-
strating that eCB-LTD can, in fact, be induced in dSPNs and
iSPN (Bagetta et al., 2011; Wang et al., 2006). These studies
argue that the D2R dependency of eCB-LTD is mediated by
disinhibition of cholinergic interneurons through M1 muscarinic
receptors (Wang et al., 2006). A recent review article byCalabresi
and colleagues (Calabresi et al., 2014) points out that crosstalk
of different neuromodulatory systems, including dopamine,
acetylcholine, eCB, and nitric oxide, might bridge the dichotomy
between dSPNs and iSPNs. Depending on the experimental
paradigms used, including stimulation electrode placement,
stimulation intensity, slice preparation method (i.e., coronal
versus parahorizontal), different neuromodulatory systems
might be recruited and thus account for the conflicting observa-
tions between research groups. To avoid these complications,
we used selective optogenetic activation of defined inputs to
demonstrate that both dSPNs and iSPNs are capable of ex-
pressing eCB-LTD at corticostriatal glutamatergic synapses.
We hypothesized that, because local electrical stimulation para-
digms may activate heterogeneous presynaptic inputs, dopa-
mine receptor signaling likely modulates, rather than determines,
eCB-LTD induction in the striatum (Shen et al., 2008; Surmeier
et al., 2014).
Our data directly support this conclusion. We show that eCB-
LTD at corticostriatal synapses on dSPNs and iSPNs is indistin-
guishable when induced by DHPG, which bypasses dopamine
modulation. Because DHPG-induced eCB-LTD is not sensitive
to D1R or D2R antagonists, our data suggest that eCB produc-
tion can simply be triggered by direct activation of intracellular
signaling cascades that are downstream of dopamine recep-
tors. This is consistent with previous studies that show that,
when induction paradigms recruit sufficient downstream Ca2+
signaling, activation of dopaminergic receptors is not required
for eCB-LTD (Adermark and Lovinger, 2007; Kreitzer and Mal-
enka, 2005).
The dichotomous expression of eCB-LTD in dSPNs and
iSPNs emerges when using an oSTDP protocol. We show
that oSTDP-induced eCB-LTD is subject to dopamine modula-
tion, suggesting that oSTDP activates intracellular signaling
that converges with dopamine receptor modulation. In addition,
the discrepancy between our data obtained with the oSTDP
protocol and a previous STDP plasticity study can be explained
by the general recruitment of dopamine fibers with local electri-
cal stimulations (Shen et al., 2008). Our oSTDP protocol did not
recruit dopamine fibers, and we observed eCB-LTD in dSPNs,84 Cell Reports 10, 75–87, January 6, 2015 ª2015 The Authorsbut not in iSPNs. This result is nearly identical compared to pre-
vious results obtained by using local stimulation and blockade
of dopamine receptors. Shen and colleagues demonstrated
that in the absence of D1R or D2R activity, LTD was success-
fully induced in dSPNs, but not iSPNs. We demonstrate that
oSTDP combined with D2R activation could successfully
induce eCB-LTD in iSPNs, which is consistent with previous
findings that D2R activation can rescue LTD in iSPNs in
Parkinson’s disease animal models (Shen et al., 2008; Surmeier
et al., 2014).
Previous studies have shown that LTD at corticostriatal synap-
ses can be induced with yet another STDP protocol—a single
spike followed by a single excitatory postsynaptic potential
(EPSP)—and that this LTD is modulated by dopamine receptors
(Pawlak and Kerr, 2008) and the local GABAergic circuit (Fino
and Venance, 2010). However, most of these studies did not sys-
tematically identify postsynaptic cell type (Fino and Venance,
2010), making it difficult to directly compare their results with
ours. Nevertheless, these findings, together with ours, suggest
SPN dendrites are a critical place for convergent glutamatergic,
GABAergic, and dopaminergic signaling.
Dopamine Modulation of Cell-Type-Dependent
eCB-LTD
There are several possible explanations for how the activation
of mixed inputs via electrical stimulation may cause eCB-LTD
expression in only D2R-expressing iSPNs. First, dopamine fibers
might be activated by electrical stimulation and lead to dopa-
mine receptor activation. D2R activation can enhance eCB pro-
duction (Giuffrida et al., 1999; Wang et al., 2006) by activating
Gbg and phospholipase C signaling, facilitating eCB-LTD in
iSPNs (Hernandez-Lopez et al., 2000; Kreitzer and Malenka,
2007). Conversely, D1R activation in dSPNs can shift synaptic
plasticity toward long-term potentiation (LTP) (Calabresi et al.,
1992; Kerr and Wickens, 2001; Shen et al., 2008) by enhancing
postsynaptic responsiveness or, presumably, by inhibiting Gq
through a protein kinase A to RGS4 signaling pathway (Lerner
and Kreitzer, 2012; Surmeier et al., 2014). Second, electrical
stimulation may also activate cholinergic fibers, which would
enhance the muscarinic tone in the striatum. M1 muscarinic re-
ceptors preferentially modulate Kir2 channels in iSPN dendrites
(Shen et al., 2007), which in turn preferentially enhance iSPN
dendritic excitability. Because iSPNs are more excitable than
dSPNs (Day et al., 2008; Kreitzer andMalenka, 2007), they might
favor eCB production in response to synaptic stimulation and
postsynaptic depolarization. In our study, we utilized optoge-
netic activation that avoids these complications. With this direct
and selective methodology, we demonstrated that both dSPNs
and iSPNs are capable of expressing eCB-LTD at corticostriatal
glutamatergic synapses using DHPG combined with mild
depolarization. Our findings suggest that striatal eCB-LTD is
not cell-type dependent, per se. We postulate that the absence
of eCB-LTD in dSPNs, as reported by Kreitzer and Malenka
(2007), may in fact be the consequence of activating D1Rs,
which suppress eCB release and thus prevent the eCB-LTD
in dSPNs. Therefore, depending on the stimulation paradigm
used, synaptic plasticity in striatum can be fine-tuned by
different G protein-coupled receptors (Surmeier et al., 2014).
It is interesting that the oSTDP protocol induced eCB-LTD only
in dSPNs and not in iSPNs. Why do iSPNs lack LTD when dopa-
mine release is not triggered? It is possible that other modulatory
systems are engaged. In addition to D2Rs, iSPNs also express
adenosine 2A receptor (A2AR) (Schiffmann et al., 2007). Tonic
activation of A2ARs by extracellular adenosine may suppress
LTD induction via activating downstreamGs signaling pathways,
which counteract the Ca2+ signaling required for eCB production
(Higley and Sabatini, 2010; Lerner et al., 2010; Shen et al., 2008;
Surmeier et al., 2014). dSPNsdo not expressA2ARs, but a similar
role is thought to be carried out by D1Rs (Surmeier et al., 2014). It
is also possible that D1R activation suppresses LTD induction in
dSPNsby activating theGs signaling pathway (Figure 5F). Our re-
sults further support the conclusion that dopamine, together with
adenosine andacetylcholine, plays amodulatory role in eCB-LTD
induction at corticostriatal synapses.
Input-Specific eCB-LTD on Striatal SPNs
Divergent long-term plasticity at corticostriatal and thalamos-
triatal synapses has functional consequences: corticostriatal
signaling is thought to play a role in cognitive and motivational
goal-directed behavior and associative learning (Graybiel,
2000), while thalamostriatal projections convey salient sensory
stimuli and are involved in attention shift (Ding et al., 2010;Matsu-
moto et al., 2001; Minamimoto et al., 2009). The differences we
observed in thephysiological properties of corticostriatal and tha-
lamostriatal synapses on SPNs are consistent with this functional
divergence. The postsynaptic NMDAR component was signifi-
cantly larger at corticostriatal synapses than at thalamostriatal
synapses (Figures 1 and S3) (Ding et al., 2008). The relative
abundance of NMDARs at corticostriatal synapses suggests
preferential LTP induction in response to high-frequency afferent
stimulation. Thepresenceof eCB-LTDatcorticostriatal synapses,
asdemonstrated in thecurrent study, suggests that corticostriatal
synapses exhibit a bidirectional plasticity that can be potentiated
or depressed (Fino et al., 2005; Shen et al., 2008). These abilities
are critical formotor learning and adaptive behavior (Costa, 2007;
Koralek et al., 2012). Thalamostriatal signaling, in contrast, is
thought to transmit salient sensory events and to play a role
in attention and arousal, rather than learning-related plasticity
(Bradfield et al., 2013;Matsumoto et al., 2001). Therefore, lacking
CB1Rs at presynaptic thalamostriatal terminals circumvents the
effects of eCB spillover, ensuring that these synapses preserve
their ability to redirect attention toward salient stimuli.
Although CB1Rs are only nominally expressed at thalamos-
triatal axons, thalamostriatal synapses are still capable of
undergoing long-term plasticity. It is interesting that the oSTDP
protocol could induce an NMDAR-dependent LTD that is insen-
sitive to eCB. It has been shown that thalamostriatal inputs from
Pf exhibit NMDAR-dependent LTD, regardless of using pre-post
or post-pre STDP induction protocols (Ellender et al., 2013). This
could imply that when salient stimuli emerge with background
stimulation, attentional shift mediated by thalamostriatal system
wanes. Short-term synaptic depression and NMDAR-dependent
LTD may be responsible for behavioral desensitization and
attentional shift when salient events become background.
Input-specific long-term plasticity, on the other hand, could be
a general mechanism for motor learning and finemovement con-trol. For example, serotonin-mediated LTD at striatal SPNs has
been proposed to be restricted to cortical inputs (Mathur et al.,
2011), whereas opioids induce LTD selectively at thalamostriatal
synapses in the dorsal striatum (Atwood et al., 2014a). These
findings, together with our present study, suggest a common
input-specific plasticity mediated by presynaptic Gi/o coupled
receptors at striatal excitatory synapses (Atwood et al., 2014b).
It is possible that, during exercise or other repeated training
paradigms for motor learning, different long-term plasticity
mechanisms are engaged during different activity patterns of
postsynaptic SPNs, ultimately fine tuning convergent inputs for
precise movement control. The findings from our studies not
only provide a neural substrate for corticothalamostriatal-rele-
vant behaviors but also open avenues for the study of interac-
tions of synaptic plasticity at highly convergent and intermingled
synaptic inputs.
EXPERIMENTAL PROCEDURES
Animals
Adult (8–12 weeks) mice were used for this study. Stereotaxic injections were
performed on postnatal day 17 (P17)–P18 Vglut2-Cre;Drd1-tdTomato or
Vglut2- Cre;Drd2-eGFPmice and used at least 8 weeks postinjection. Injection
sites were verified in slices fixed after each recording session (Figure S1A). All
procedures were approved by Stanford University’s Administrative Panel on
Laboratory Animal Care.
Electrophysiology
Oblique horizontal brain slices (300 mm) containing the dorsal striatum
(Figure 1C) were obtained using standard techniques (Ding et al., 2008).
Whole-cell voltage- or current-clamp recordings were conducted using
cesium methylsulfonate-based or potassium methylsulfonate-based internal
solutions, respectively. Picrotoxin (50 mM) was included in the artificial cere-
brospinal fluid to block GABAA receptors in experiments with voltage-clamp
recording. Datawere recordedwith custom-made softwarewritten inMATLAB
(MathWorks).
Optogenetic Stimulation
To stimulate ChR2-expressing axons, blue laser light (450 nm) was focused on
the back focal plane of the objective. For the oSTDP induction paradigm, back-
propagating APs (bAPs) were evoked by somatic current injection (2 ms, 2 nA).
The LTD induction protocol consisted of 20 trains of five bursts (5 Hz), repeated
at 1 Hz. The burst was composed of three bAPs followed by an EPSP evoked
by blue laser stimulation with a 10 ms delay. Recorded neurons were depolar-
ized to 70 mV during the induction period (Figure 5A). The long-term
changes in EPSCs/ EPSPs were calculated by averaging EPSC/EPSP ampli-
tudes 25–30 min following the induction protocol and comparing the value
to the average EPSC/ EPSP during the baseline. PPRs were measured by
dividing the peak of the second EPSC by the first EPSC.
For detailed methods, see Supplemental Experimental Procedures.
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